For as many as one in five Australians, the use of continuous positive airway pressure (CPAP) treatment for sleep apnoea is now a part of their nightly routine. Where ever they plan to lay their heads ...
Dublin, Oct. 08, 2021 (GLOBE NEWSWIRE) -- The "CPAP Market Shares, Strategy, and Forecasts, Worldwide, 2021 to 2027" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's ...
The FDA slapped the April 15 recall of Fisher & Paykel Healthcare's Infant Nasal CPAP Prongs and Bubble CPAP Starter Kits with its most severe label, meaning the now Class I recall involves ...
Hosted on MSN
Should I buy Fisher & Paykel or ResMed shares?
Investors looking for exposure to the growing field of respiratory healthcare and sleep apnoea treatment may find themselves comparing two ASX-listed giants: Fisher & Paykel Healthcare Corporation Ltd ...
Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome
The assessment report included 48 randomised controlled trials (RCTs) that compared the efficacy of CPAP with placebo or usual care or dental devices. Submissions were obtained from 3 manufacturers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results